Lee, C., Lee, Y. B., Kim, M. A., Jang, H., Oh, H., Kim, S. W., . . . Kim, Y. J. (2020). Effectiveness of nivolumab versus regorafenib in hepatocellular carcinoma patients who failed sorafenib treatment. Clin Mol Hepatol.
Stile di citazione ChicagoLee, Cheol-Hyung, et al. "Effectiveness of Nivolumab Versus Regorafenib in Hepatocellular Carcinoma Patients Who Failed Sorafenib Treatment." Clin Mol Hepatol 2020.
Citazione MLALee, Cheol-Hyung, et al. "Effectiveness of Nivolumab Versus Regorafenib in Hepatocellular Carcinoma Patients Who Failed Sorafenib Treatment." Clin Mol Hepatol 2020.
Attenzione: Queste citazioni potrebbero non essere precise al 100%.